{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:42:33Z","timestamp":1777956153842,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R42GM131433"],"award-info":[{"award-number":["1R42GM131433"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpet.2025.103660","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:18:41Z","timestamp":1752625121000},"page":"103660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Experimental and computational approaches for evaluating molecule interactions with equilibrative nucleoside transporters 1 and 2"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7509-4684","authenticated-orcid":false,"given":"Lucy J.","family":"Martinez-Guerrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4015-6410","authenticated-orcid":false,"given":"Patricia A.","family":"Vignaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique O.","family":"Farrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2180-840X","authenticated-orcid":false,"given":"Joshua S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renuka","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-5790","authenticated-orcid":false,"given":"Sean","family":"Ekins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan J.","family":"Cherrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2025.103660_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15257770.2016.1210805","article-title":"Equilibrative nucleoside transporters\u2014a review","volume":"36","author":"Boswell-Casteel","year":"2017","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.jpet.2025.103660_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5197626","article-title":"Equilibrative nucleoside transporter 2: properties and physiological roles","volume":"2020","author":"Naes","year":"2020","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.jpet.2025.103660_bib3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cpt.2984","article-title":"Addressing the clinical importance of equilibrative nucleoside transporters in drug discovery and development","volume":"114","author":"Hau","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jpet.2025.103660_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/dmd.122.001186","article-title":"Drug transporters at the human blood-testis barrier","volume":"51","author":"Hau","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpet.2025.103660_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/978-981-13-7647-4_10","article-title":"Roles of drug transporters in blood-retinal barrier","volume":"1141","author":"Liu","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jpet.2025.103660_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00952","article-title":"Nucleoside analogues as antibacterial agents. Review","volume":"10","author":"Thomson","year":"2019","journal-title":"Front Microbiol"},{"issue":"40","key":"10.1016\/j.jpet.2025.103660_bib7","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.3748\/wjg.v27.i40.6844","article-title":"Role of human nucleoside transporters in pancreatic cancer and chemoresistance","volume":"27","author":"Carter","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103660_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40262-021-01089-9","article-title":"Cladribine as a potential object of nucleoside transporter-based drug interactions","volume":"61","author":"Hermann","year":"2022","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.jpet.2025.103660_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/jpet.112.191577","article-title":"Molecular determinants of ligand selectivity for the human multidrug and toxin extrusion proteins, MATE1 and MATE2-K","volume":"341","author":"Astorga","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.jpet.2025.103660_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/clpt.2012.164","article-title":"Computational modeling to accelerate the identification of substrates and inhibitors for transporters that affect drug disposition","volume":"92","author":"Ekins","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpet.2025.103660_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-1-4939-9420-5_26","article-title":"In Silico Approaches to predict drug-transporter interaction profiles: data mining, model generation, and link to cholestasis","volume":"1981","author":"Jain","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"9","key":"10.1016\/j.jpet.2025.103660_bib12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1039\/C6MD00207B","article-title":"From linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporter","volume":"7","author":"Zdrazil","year":"2016","journal-title":"MedChemComm"},{"issue":"8","key":"10.1016\/j.jpet.2025.103660_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.jpet.2025.103660_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejps.2005.09.013","article-title":"Computational approaches to modeling drug transporters","volume":"27","author":"Chang","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.jpet.2025.103660_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/molpharm.120.000169","article-title":"Predicting drug interactions with human equilibrative nuceloside transporters 1 and 2 using functional knockout cell lines and bayesian modeling","volume":"99","author":"Miller","year":"2021","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103660_bib16","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1124\/mol.117.111443","article-title":"Assessment of substrate-dependent ligand interactions at the organic cation transporter OCT2 using six model substrates","volume":"94","author":"Sandoval","year":"2018","journal-title":"Mol Pharmacol"},{"issue":"11","key":"10.1016\/j.jpet.2025.103660_bib17","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1021\/acs.molpharmaceut.2c00662","article-title":"Machine learning models identify new inhibitors for human OATP1B1","volume":"19","author":"Lane","year":"2022","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.jpet.2025.103660_bib18","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1124\/dmd.115.064956","article-title":"Making transporter models for drug\u2013drug interaction prediction mobile","volume":"43","author":"Ekins","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.jpet.2025.103660_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/dmd.121.000423","article-title":"Multiple computational approaches for predicting drug interactions with human equilibrative nucleoside transporter 1","volume":"49","author":"Miller","year":"2021","journal-title":"Drug Metab Dispos"},{"issue":"1-3","key":"10.1016\/j.jpet.2025.103660_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejphar.2003.08.076","article-title":"Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney","volume":"479","author":"Mangravite","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103660_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/jpet.117.242552","article-title":"Correlation between apparent substrate affinity and OCT2 transporter turnover","volume":"362","author":"Severance","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.jpet.2025.103660_bib22","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/acs.molpharmaceut.4c00984","article-title":"Computational approaches for predicting drug interactions with human organic anion transporter 4 (OAT4)","volume":"22","author":"Martinez-Guerrero","year":"2025","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.jpet.2025.103660_bib24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.jpet.2025.103660_bib25","series-title":"Advances in Neural Information Processing Systems 36","article-title":"Class-conditional conformal prediction with many classes","author":"Ding","year":"2024"},{"issue":"1-2","key":"10.1016\/j.jpet.2025.103660_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10472-013-9368-4","article-title":"Cross-conformal predictors","volume":"74","author":"Vovk","year":"2015","journal-title":"Ann Math Artif Intell"},{"issue":"5","key":"10.1016\/j.jpet.2025.103660_bib27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0026-895X(25)12451-6","article-title":"Binding of the nucleoside transport inhibitor nitrobenzylthioinosine to HeLa cells","volume":"13","author":"Lauzon","year":"1977","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103660_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/bj2000295","article-title":"Binding of nitrobenzylthioinosine to high-affinity sites on the nucleoside-transport mechanism of HeLa cells","volume":"200","author":"Dahlig-Harley","year":"1981","journal-title":"Biochem J"},{"issue":"7","key":"10.1016\/j.jpet.2025.103660_bib29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1124\/dmd.120.090720","article-title":"Nucleoside reverse transcriptase inhibitor interaction with human equilibrative nucleoside transporters 1 and 2","volume":"48","author":"Miller","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpet.2025.103660_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1613\/jair.953","article-title":"SMOTE: synthetic minority over-sampling technique","volume":"16","author":"Chawla","year":"2002","journal-title":"J Artif Intell Res"},{"issue":"1-3","key":"10.1016\/j.jpet.2025.103660_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"13","key":"10.1016\/j.jpet.2025.103660_bib32","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1021\/acs.jmedchem.2c00473","article-title":"Rings in clinical trials and drugs: present and future","volume":"65","author":"Shearer","year":"2022","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.jpet.2025.103660_bib33","first-page":"371","article-title":"A tutorial on conformal prediction","volume":"9","author":"Shafer","year":"2008","journal-title":"J Mach Learn Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103660_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/clpt.2013.74","article-title":"Emerging transporters of clinical importance: an update from the International Transporter Consortium","volume":"94","author":"Hillgren","year":"2013","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jpet.2025.103660_bib35","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/2472555219870123","article-title":"Current progress on equilibrative nucleoside transporter function and inhibitor design","volume":"24","author":"Rehan","year":"2019","journal-title":"SLAS Discov"},{"issue":"3","key":"10.1016\/j.jpet.2025.103660_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.15537\/1658-3175.4248","article-title":"Natural product and drugs interactions, its clinical implication in drug therapy management","volume":"29","author":"Joshi","year":"2008","journal-title":"Saudi Med J"},{"key":"10.1016\/j.jpet.2025.103660_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.126578","article-title":"Nobiletin, sinensetin, and tangeretin are the main perpetrators in clementines provoking food-drug interactions in vitro","volume":"319","author":"Weiss","year":"2020","journal-title":"Food Chem"},{"issue":"2","key":"10.1016\/j.jpet.2025.103660_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5001\/omj.2011.21","article-title":"Food-drug interactions","volume":"26","author":"Bushra","year":"2011","journal-title":"Oman Med J"},{"key":"10.1016\/j.jpet.2025.103660_bib39","series-title":"Flavonoids and Related Compounds as Nucleoside Transporter Inhibitors","author":"Pimple","year":"2008"},{"issue":"20","key":"10.1016\/j.jpet.2025.103660_bib40","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.jpet.2025.103660_bib41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/17460441.2016.1201262","article-title":"A renaissance of neural networks in drug discovery","volume":"11","author":"Baskin","year":"2016","journal-title":"Expert Opin Drug Discov"},{"issue":"11","key":"10.1016\/j.jpet.2025.103660_bib42","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1007\/s11095-016-2029-7","article-title":"The next era: Deep learning in pharmaceutical research","volume":"33","author":"Ekins","year":"2016","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.jpet.2025.103660_bib43","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1021\/acs.molpharmaceut.7b00578","article-title":"Comparison of deep learning with multiple machine learning methods and metrics using diverse drug discovery datasets","volume":"14","author":"Korotcov","year":"2017","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.jpet.2025.103660_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s42004-024-01220-4","article-title":"The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applications","volume":"7","author":"Snyder","year":"2024","journal-title":"Commun Chem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:16:26Z","timestamp":1777943786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0022356525398733"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103660","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental and computational approaches for evaluating molecule interactions with equilibrative nucleoside transporters 1 and 2","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103660"}}